Chong Liu
Zhejiang, 318000, China
NCT Number: NCT06188858
Our aim was to identify optimal incision sites for LVA in extremity lymphedema that would result in the most effective drainage effect for reducing limb edema and enhancing patients' quality of life.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Zhejiang, 318000, China
designing the optimal incision sites and identifying functional lymphatic vessels imaging is crucial for success, primarily due to its efficacy in draining edematous lymphatic fluid and reducing swelling in patients with lymphedema. In this study, we conducted patients with LVA lymphedema to investigate the correlation between LVA incision design, intraoperative functional lymphatic vessel assessment, postoperative limb reduction, and patient satisfaction.
question 1:Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity lymphedema
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Aged 18-80 years; Lymphedema and swelling of the limbs for more than 3 months
-
Exclusion criteria
Time frame: through study completion, an average of 4 year
stage 0-3
Time frame: through study completion, an average of 4 year
Optimal Incision Site Design for Lymphaticovenular Anastomosis
Time frame: through study completion, an average of 4 year
intraoperative functional lymphatic vessel assessment
Time frame: through study completion, an average of 4 year
postoperative limb reduction and patient satisfaction
Taizhou Hospital
Other
Optimal Incision Site Design for Lymphaticovenular Anastomosis in Extremity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07414615
Hemic and Lymphatic Diseases, Lymphatic Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06905639
Behavior, Breast Diseases
Ponferrada, León, Spain
View Trial DetailsNCT02506530
Breast Diseases, Breast Neoplasms
Toulouse, Midi Pyrenees, France
View Trial DetailsNCT07612865
Cardiovascular Diseases, Cervical Cancer
Ürümqi, Xinjiang Uygur Autonomous Region, China
View Trial Details